Article Information
History
- February 25, 2020.
Article Versions
- Version 1 (December 31, 2019 - 12:02).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Harriet Hunter*,1,
- Dana de Gracia Hahn*,1,
- Amedine Duret*,1,
- Yu Ri Im*,1,
- Qinrong Cheah1,
- Jiawen Dong1,
- Madison Fairey1,
- Clarissa Hjalmarsson1,
- Alice Li1,
- Hong Kai Lim1,
- Lorcán McKeown1,
- Claudia-Gabriela Mitrofan1,
- Raunak Rao1,
- Mrudula Utukuri1,
- Ian A. Rowe2 and
- Jake P. Mann3,†
- 1School of Clinical Medicine, University of Cambridge, Cambridge, UK
- 2Leeds Institute for Medical Research & Leeds Institute for Data Analytics, University of Leeds, Leeds, UK
- 3Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- ↵†Correspondence: Dr. Jake P Mann, Metabolic Research Laboratories, Level 4, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, CB2 0QQ, jm2032{at}cam.ac.uk, Tel: +44 1223 336792, Fax: +44 1223 330598
↵* These authors contributed equally.
Posted February 25, 2020.
What influences treatment response in animal models of non-alcoholic fatty liver disease? A meta-analysis with meta-regression
